186: Pharma 2026: A CEO Strategic Framework for Global Volatility
Pharma 2026: A CEO Strategic Framework for Global Volatility The pharmaceutical industry is entering one of the most volatile periods in its history. Political shifts, supply chain fragility, regulatory uncertainty, geopolitical tension, and accelerating digital disruption are no longer isolated risks—they are compounding forces reshaping how pharma leaders must think, decide, and act. In this […]